Susceptibility of Klebsiella spp. to the crude extract of Thuja orientalis
DOI:
https://doi.org/10.59746/jfms.v1i1.23Keywords:
Thuja orientalis, Klebsiella, Urinary tract infection (UTI), Antibacterial activity.Abstract
The present study was conducted to investigate the antibacterial activity of Thuja orientalis extract against fourteen isolates of Klebsiella from urinary tract infection patients. Antibiotic susceptibility test was done against eight antibiotics to determine the bacterial resistance. The highest bacterial resistance was against Cefixime and Trimethoprim (100%), while the lowest resistance was against Ciprofloxacin, Levofloxacin and Imepenem (28.57%). Finally the effect of Thuja oriantalis plant extract was tested and results showed that, this plant extract has marked inhibitory effect against all Klebsiella isolates.
References
• Akinpelu S, Ajayi A, Smith SI. and Adeleye AI. (2020). Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital. BMC Research Notes; 13(1): 1-5.
• Bissa S, Bohra A. and Bohra A.(2008). Antibacterial potential of three naked-seeded (Gymnosperm) plants. Natur. Prod. Radia.; 7(5): 420-425.
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 30th ed. CLSI. Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
• Das DC, Sinha NK, Patsa MK. and Das M. (2015). Investigation of herbals for the treatment of leucorrhoea from south west Bengal, India. International Journal of Bioassays; 4(11): 4555- 4559.
• DH B, Holt G, Krieg NR. and Sneath PHA. (1994). Bergey’s manual of determinative bacteriology. Williams & Wilkins, Baltimore Bernfeld P (1955) Amylases, a and b. Method Enzymol, 1, 149158.
• Digrak M, Bagci E. and Alma MH. (2002). Antibiotic action of seed lipids from five tree species grown in Turkey. Pharmaceutical biology; 40(6): 425-428.
• Joginder SD, Pooja S. and Ashok K. (2013). Antimicrobial potential of various fractions of Thuja orientalis. African Journal of Microbiology Research; 7(25): 3179-3186.
• Kamona ZK, (2011). Determination of Antimicrobial Activity of Thuja orientalis Against Some Pathogenic Microorganisms. Journal of the college of basic education. Al-Mustansyriah. 68: 69-74.
• Kaya G, Karakaya R, Tilgel E, Sandikci M, Yucel E, Cicek G. and Erenler R. (2014). Essential oil constituents of Thuja orientalis berries. Journal of new results in science; 3(7): 1-6.
• Khubeiz M.J, Mansour G. and Zahraa B. (2016). Antibacterial and phytochemical investigation of Thuja orientalis (L.) leaves essential oil from Syria. Int. J. Curr. Pharmaceut. Rev. Res.; 7: 243-247.
• Ktari S, Arlet G, Mnif B, Gautier V, Mahjoubi F, Ben Jmeaa M. and Hammami A. (2006). Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian university hospital. Antimicrobial agents and chemotherapy; 50(12): 4198-4201.
• Lane DR, and Takhar SS. (2011). Diagnosis and management of urinary tract infection and pyelonephritis. Emergency medicine clinics; 29(3): 539-552.
• Ololade ZS, Fakankun OA, Alao FO. and Udi OU. (2014). Phytochemical and Therapeutic Studies of the Fruit essential oil of Thuja orientalis from Nigeria. Glob. J. Sci. Front. Res. B Chem.; 1: 15-20.
• Olonisakin A, Abugan AV. and Akinnifesi TA. (2017). Essential oil composition and bioactivity of Thuja orientalis and Eucalyptus camaldulensis. Ife Journal of Science; 19(2): 353-361.
• Olson PD. (2018). Sex Differences in Uropathogenic Escherichia coli Urinary Tract Infection. Washington University in St. Louis.
• Oskay M, Oskay D. and Kalyoncu F. (2009). Activity of some plant extracts against multi-drug resistant human pathogens. Iranian Journal of Pharmaceutical Research; 8 (4): 293-300.
• Özgen AO and Eyüpoğlu OE. (2020). Antibiotic susceptibility of Klebsiella pneumoniae strains isolated from clinical samples. Journal of the Turkish Chemical Society Section A: Chemistry; 7(1): 319-326.
• Parker V, Giles M, Graham L, Suthers B, Watts W, O’Brien T. and Searles A. (2017). Avoiding inappropriate urinary catheter use and catheter-associated urinary tract infection (CAUTI): a pre-post control intervention study. BMC health services research; 17(1): 1-9.
• Podschun R and Ullmann U. (1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical microbiology reviews; 11(4): 589-603.
• Ryan KJ and Ray CG. (2004). Medical microbiology. McGraw Hill; 4(370).
• Shahwany AW, Tawfeeq HK. and Hamed SE. (2016). Antibacterial and anti-biofilm activity of three phenolic plant extracts and silver nanoparticles on Staphylococcus aureus and Klebsiella pneumoniae. J Biomed Biotechnol; 4; 12-18.
• Sharmeen R, Hossain MN, Rahman MM, Foysal MJ. and Miah MF. (2012). In-vitro antibacterial activity of herbal aqueous extract against multi-drug resistant Klebsiella sp. isolated from human clinical samples. International Current Pharmaceutical Journal; 1(6): 133-137.
• Smelov V, Naber K. and Johansen TEB. (2016). Improved classification of urinary tract infection: future considerations. European Urology Supplements; 15(4): 71-80.
• Stefaniuk E, Suchocka U, Bosacka K. and Hryniewicz W. (2016). Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland. European Journal of Clinical Microbiology & Infectious Diseases; 35(8): 1363-1369.
• Terlizzi ME, Gribaudo G. and Maffei ME. (2017). UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Frontiers in microbiology; 8: 1566.
• Vandepitte J, Verhaegen J, Engbaek K, Piot P, Heuck CC, Rohner P. and Heuck CC. (2003). Basic laboratory procedures in clinical bacteriology. World Health Organization.
• Yan JJ, Ko WC, Tsai SH, Wu HM. and Wu JJ. (2001). Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla IMP-8 in a university medical center in Taiwan. Journal of clinical microbiology; 39(12): 4433-4439.
